Bernadette Marquez-Nostra

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

Cancers

JCO precision oncology

European journal of nuclear medicine and molecular imaging

Science translational medicine

Yale University

University of California Davis (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Yale University Jul 01 2017

United States

Assistant Professor :: Radiology and Biomedical Imaging

Education History

University of California Davis Sep 25 2006 - Dec 11 2011

United States

PHD :: Chemistry

California State University Fullerton Aug 25 2000 - May 10 2005

United States

BSC :: Chemistry and Biochemistry

Publications

David G Su, Dijana Djureinovic, David A Schoenfeld, Bernadette Marquez-Nostra, Kelly Olino, Lucia Jilaveanu, Harriet M Kluger
Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma. JCO precision oncology 8 (2024)
David G Su, Dijana Djureinovic, David A Schoenfeld, Bernadette Marquez-Nostra, Kelly Olino, Lucia Jilaveanu, Harriet M Kluger
Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma. JCO precision oncology 8 (2024)
David G Su, Dijana Djureinovic, David A Schoenfeld, Bernadette Marquez-Nostra, Kelly Olino, Lucia Jilaveanu, Harriet M Kluger
Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma. JCO precision oncology 8 (2024)
Ziqi Li, Erika Belitzky, Ondrej Blaha, Alessandra Cavaliere, Samantha R Katz, Mariam S Aboian, Lindy Melegari, Khashayar Rajabimoghadam, Stephen Kurpiewski, Xiaohua Zhu, Bernadette Marquez-Nostra
ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer. Cancers 15 (5) (2023)
Ziqi Li, Erika Belitzky, Ondrej Blaha, Alessandra Cavaliere, Samantha R Katz, Mariam S Aboian, Lindy Melegari, Khashayar Rajabimoghadam, Stephen Kurpiewski, Xiaohua Zhu, Bernadette Marquez-Nostra
ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer. Cancers 15 (5) (2023)
Ziqi Li, Erika Belitzky, Ondrej Blaha, Alessandra Cavaliere, Samantha R Katz, Mariam S Aboian, Lindy Melegari, Khashayar Rajabimoghadam, Stephen Kurpiewski, Xiaohua Zhu, Bernadette Marquez-Nostra
ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer. Cancers 15 (5) (2023)
Ziqi Li, Erika Belitzky, Ondrej Blaha, Alessandra Cavaliere, Samantha R Katz, Mariam S Aboian, Lindy Melegari, Khashayar Rajabimoghadam, Stephen Kurpiewski, Xiaohua Zhu, Bernadette Marquez-Nostra
ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer. Cancers 15 (5) (2023)
Minsoo Khang, Ju-Hyun Lee, Teresa Lee, Hee Won Suh, Supum Lee, Alessandra Cavaliere, Amy Rushing, Luiz Henrique Medeiros Geraldo, Erika Belitzky, Samantha M Rossano, Henk M De Feyter, Kwangsoo Shin, Anita Huttner, Martine F Roussel, Jean-Léon Thomas, Richard E Carson, Bernadette Marquez-Nostra, Ranjit S Bindra, W Mark Saltzman
Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma. Science translational medicine 15 (720) (2023)
Ziqi Li, Mariam S Aboian, Xiaohua Zhu, Bernadette Marquez-Nostra
Clinical Evaluation of Nuclear Imaging Agents in Breast Cancer. Cancers 14 (9) (2022)
Alessandra Cavaliere, Suxia Sun, Supum Lee, Jacob Bodner, Ziqi Li, Yiyun Huang, Sheri L Moores, Bernadette Marquez-Nostra
Development of [89Zr]ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer. European journal of nuclear medicine and molecular imaging 48 (2) (2020)

Bernadette Marquez-Nostra.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bernadette Marquez-Nostra